SCHEMBL802967

SCHEMBL802967

CC1CCCc2cc(C(=O)C(C)(C)C)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
ALOX5 P09917 1/20 0.38
HDAC6 Q9UBN7 1/20 0.35
HTR6 P50406 2/20 0.35
LMNA P02545 2/20 0.34
PDE4D Q08499 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
MAPT P10636 2/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
GAA P10253 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33
DHODH Q02127 1/20 0.33
SMYD3 Q9H7B4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL802973 0.96 ALDH1A1 (0.38) ALDH1A1ALOX5HDAC6HTR6LMNA
SCHEMBL803351 0.91 ALOX5 (0.36) ALDH1A1ALOX5HDAC6PDE4DMAPT
SCHEMBL803409 0.91 ALOX5 (0.36) ALDH1A1ALOX5HDAC6PDE4DMAPT
SCHEMBL802978 0.91 ALOX5 (0.36) ALDH1A1ALOX5HDAC6PDE4DMAPT
SCHEMBL802970 0.88 ALDH1A1 (0.39) ALDH1A1ALOX5HDAC6LMNAPDE4D
SCHEMBL803415 0.84 ALDH1A1 (0.38) ALDH1A1ALOX5HDAC6LMNAPDE4D
SCHEMBL9055964 0.83 ALDH1A1 (0.54) ALDH1A1LMNANPC1RAB9AMAPT
SCHEMBL25195403 0.82 AKR1C3 (0.44) ALDH1A1LMNANPC1MAPT
SCHEMBL802976 0.79 DRD3 (0.37) ALDH1A1ALOX5HDAC6PDE4D
SCHEMBL802974 0.79 DRD3 (0.37) ALDH1A1ALOX5HDAC6PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885ALOX5 2016/4885HDAC6 1974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.